Female Pattern Hair Loss Treatment Guidelines

First-Line Treatment

The American College of Dermatology recommends topical minoxidil as the primary evidence-based medication for female pattern hair loss, with 5% foam applied once daily or 2% solution applied twice daily showing significant efficacy in increasing hair density and count 1
Treatment with topical minoxidil must be continued indefinitely, as discontinuation leads to reversal of hair growth benefits within months 1

The combination of platelet-rich plasma (PRP) with topical minoxidil 5% demonstrates superior efficacy compared to either treatment alone and represents the most effective evidence-based approach for female pattern hair loss 1
PRP induces proliferation of dermal papilla cells, increases perifollicular vascularization, and accelerates the telogen-to-anagen hair cycle transition 1
Studies demonstrate statistically significant increases in hair density, follicle diameter, and terminal hair density with PRP treatment 2

Evaluate efficacy using multiple objective measures, including standardized photographs, trichoscopy, hair pull test, and patient self-assessment questionnaires 1
Schedule follow-up at 3 months for initial assessment, with ongoing monitoring every 3-6 months 3

Efficacy decreases with severity and duration of alopecia, so earlier intervention yields better results 1
Patient counseling about realistic expectations and treatment duration is essential to maintain adherence 3
Regular monitoring is crucial to assess response and adjust therapy 1
Address significant emotional distress and consider referral for psychological support when needed 3

Low-level laser light therapy (LLLT) three times weekly demonstrates efficacy as an adjunctive or alternative treatment 1
Cosmetic options, including wigs, hairpieces, or hair extensions, should be discussed, particularly for extensive hair loss while awaiting treatment response 3

Intralesional corticosteroids are first-line for limited patchy alopecia areata 4, 3
Minoxidil has limited evidence in alopecia areata, with response rates of only 32-33% in controlled trials 5, 6
Distinguish between pattern hair loss and alopecia areata through clinical examination and dermoscopy 3

The American Academy of Dermatology recommends low-dose oral minoxidil (1 mg daily) as an alternative when topical application is not feasible, with evidence suggesting slightly lower efficacy than topical formulations 7, 8, 9
Low-dose oral minoxidil (1 mg daily) has a safety profile with growing evidence supporting tolerability at low doses, though adverse effects remain a concern and require monitoring 7, 8, 9